GAGE6, a member of the G antigen protein family, can be activated by various chemical compounds through different signaling pathways. Compounds that increase intracellular levels of cyclic AMP (cAMP) are particularly effective in modulating the activity of GAGE6. By directly stimulating adenylate cyclase or inhibiting phosphodiesterase activity, certain molecules elevate cAMP levels, which in turn activate protein kinase A (PKA). PKA then phosphorylates various substrates within the cell, including GAGE6, which may increase its functional activity. Additionally, other compounds that act as ionophores can alter intracellular calcium concentrations, leading to the activation of calcium-dependent protein kinases. These kinases can phosphorylate proteins, potentially including GAGE6, thus enhancing its activity within cellular signaling networks.
Moreover, the activation of GAGE6 can also be influenced by pathways initiated by external stimuli such as hormones and growth factors that trigger receptor-mediated signaling cascades. For instance, stimulation of beta-adrenergic receptors or the insulin receptor sets off a series of phosphorylation events that can culminate in the activation of GAGE6. The MAPK/ERK pathway, often activated by growth factors, represents another route through which the activity of GAGE6 might be modulated. This pathway typically culminates in the phosphorylation of various proteins, which may include GAGE6, thereby influencing its role in cell survival and proliferation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
This diterpene acts directly on adenylate cyclase, increasing cyclic AMP (cAMP) levels in cells. Elevated cAMP activates protein kinase A (PKA), which can phosphorylate a variety of proteins, including GAGE6, thereby increasing its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can lead to the phosphorylation of proteins involved in cell survival and proliferation, potentially enhancing the functional activity of GAGE6 as part of downstream signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
As a calcium ionophore, ionomycin increases intracellular calcium levels, which can activate calcium-dependent protein kinases, potentially increasing the phosphorylation and activation of GAGE6. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
This synthetic catecholamine agonist stimulates beta-adrenergic receptors leading to increased cAMP production via adenylate cyclase activation, which can enhance the PKA-mediated activation of GAGE6. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin receptor activation triggers a cascade of phosphorylation events, including the activation of the PI3K/Akt pathway, which can lead to the activation of proteins involved in cell survival, potentially including GAGE6. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
This calcium ionophore increases intracellular calcium, activating calcium/calmodulin-dependent protein kinases, which could lead to increased activity of GAGE6 through phosphorylation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
This cAMP analog is resistant to degradation by phosphodiesterases and can activate PKA, which may increase the phosphorylation and activity of GAGE6. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, leading to increased levels of cAMP and activation of PKA that could enhance the functional activity of GAGE6. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
As a selective inhibitor of phosphodiesterase 5, zaprinast increases cAMP in cells, which can promote PKA activity and potentially enhance the activation of GAGE6. | ||||||